252 related articles for article (PubMed ID: 34193753)
1. Diffuse large B-cell lymphoma (DLBCL) with significant intravascular invasion. Close resemblance of its clinicopathological features to intravascular large B-cell lymphoma, but not to DLBCL-not otherwise specified.
Itami H; Nakamine H; Kubo M; Ogawa K; Tani R; Nakamura S; Takeda M; Nitta Y; Uchiyama T; Fujii T; Hatakeyama K; Ohbayashi C
J Clin Exp Hematop; 2021 Sep; 61(3):152-161. PubMed ID: 34193753
[TBL] [Abstract][Full Text] [Related]
2. PD-L1 (SP142) expression in neoplastic cells predicts a poor prognosis for patients with intravascular large B-cell lymphoma treated with rituximab-based multi-agent chemotherapy.
Suzuki Y; Kohno K; Matsue K; Sakakibara A; Ishikawa E; Shimada S; Shimada K; Mabuchi S; Takahara T; Kato S; Nakamura S; Satou A
Cancer Med; 2020 Jul; 9(13):4768-4776. PubMed ID: 32367674
[TBL] [Abstract][Full Text] [Related]
3. Intravascular large B-cell lymphoma in the United States (US): a population-based study using Surveillance, Epidemiology, and End Results program and National Cancer Database.
Rajyaguru DJ; Bhaskar C; Borgert AJ; Smith A; Parsons B
Leuk Lymphoma; 2017 Sep; 58(9):1-9. PubMed ID: 28278725
[TBL] [Abstract][Full Text] [Related]
4. Immune evasion-related extranodal large B-cell lymphoma: A report of six patients with neoplastic PD-L1-positive extranodal diffuse large B-cell lymphoma.
Suzuki Y; Sakakibara A; Shimada K; Shimada S; Ishikawa E; Nakamura S; Kato S; Takahara T; Asano N; Satou A; Kohno K
Pathol Int; 2019 Jan; 69(1):13-20. PubMed ID: 30601579
[TBL] [Abstract][Full Text] [Related]
5. Frequent genetic alterations in immune checkpoint-related genes in intravascular large B-cell lymphoma.
Shimada K; Yoshida K; Suzuki Y; Iriyama C; Inoue Y; Sanada M; Kataoka K; Yuge M; Takagi Y; Kusumoto S; Masaki Y; Ito T; Inagaki Y; Okamoto A; Kuwatsuka Y; Nakatochi M; Shimada S; Miyoshi H; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Shiozawa Y; Nannya Y; Okabe A; Kohno K; Atsuta Y; Ohshima K; Nakamura S; Ogawa S; Tomita A; Kiyoi H
Blood; 2021 Mar; 137(11):1491-1502. PubMed ID: 33512416
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Value of Concurrent Expression of C-MYC and BCL2 in Intravascular Large B-Cell Lymphoma: A 10-Year Retrospective Study.
Boonsakan P; Iamsumang W; Chantrathammachart P; Chayavichitsilp P; Suchonwanit P; Rutnin S
Biomed Res Int; 2020; 2020():1350820. PubMed ID: 32566654
[TBL] [Abstract][Full Text] [Related]
7. Comparative clinicopathological study of primary CNS diffuse large B-cell lymphoma and intravascular large B-cell lymphoma.
Imai H; Shimada K; Shimada S; Abe M; Okamoto M; Kitamura K; Kinoshita T; Shiraishi T; Nakamura S
Pathol Int; 2009 Jul; 59(7):431-7. PubMed ID: 19563405
[TBL] [Abstract][Full Text] [Related]
8. Definition, diagnosis, and management of intravascular large B-cell lymphoma: proposals and perspectives from an international consensus meeting.
Ponzoni M; Ferreri AJ; Campo E; Facchetti F; Mazzucchelli L; Yoshino T; Murase T; Pileri SA; Doglioni C; Zucca E; Cavalli F; Nakamura S
J Clin Oncol; 2007 Jul; 25(21):3168-73. PubMed ID: 17577023
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like Growth Factor II mRNA-binding Protein 3 is a Highly Sensitive Marker for Intravascular Large B-cell Lymphoma: Immunohistochemical Analysis of 152 Pathology Specimens From 88 Patients.
Saka M; Fujimoto M; Mizoguchi K; Tsujimura M; Saeki M; Hirata M; Shibuya S; Odani K; Sakurai T; Yuba Y; Moriyoshi K; Nakajima N; Sumiyoshi S; Kono F; Ono K; Shirase T; Watanabe C; Yoshizawa A; Haga H
Am J Surg Pathol; 2024 Jun; 48(6):671-680. PubMed ID: 38497417
[TBL] [Abstract][Full Text] [Related]
10. Concomitant subcutaneous intravascular lymphoma lesions in a patient with cardiac diffuse large B-cell lymphoma: is intravascular lymphoma a distinct clinical entity?
Abe Y; Usui Y; Narita K; Takeuchi M; Matsue K
Int J Hematol; 2018 Dec; 108(6):637-639. PubMed ID: 30196477
[TBL] [Abstract][Full Text] [Related]
11. [Diffuse large B-cell lymphoma relapsing with intravascular large B-cell lymphoma-like perivascular and intravascular lesions].
Ishikawa T; Fukumi T; Moriyama T; Murakami H; Nagakita K; Yoshioka T; Makita M; Shinno Y; Sunami K
Rinsho Ketsueki; 2019; 60(10):1455-1461. PubMed ID: 31695007
[TBL] [Abstract][Full Text] [Related]
12. De novo CD5+ diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients.
Yamaguchi M; Seto M; Okamoto M; Ichinohasama R; Nakamura N; Yoshino T; Suzumiya J; Murase T; Miura I; Akasaka T; Tamaru J; Suzuki R; Kagami Y; Hirano M; Morishima Y; Ueda R; Shiku H; Nakamura S
Blood; 2002 Feb; 99(3):815-21. PubMed ID: 11806981
[TBL] [Abstract][Full Text] [Related]
13. Hemophagocytosis-Related (Asian Variant) Intravascular Large B-Cell Lymphoma in a Hispanic Patient: A Case Report Highlighting a Micronodular Pattern in the Spleen.
Hall JM; Meyers N; Andrews J
Am J Clin Pathol; 2016 May; 145(5):727-35. PubMed ID: 27247375
[TBL] [Abstract][Full Text] [Related]
14. Intravascular large B-cell lymphoma (IVLBCL): a clinicopathologic study of 96 cases with special reference to the immunophenotypic heterogeneity of CD5.
Murase T; Yamaguchi M; Suzuki R; Okamoto M; Sato Y; Tamaru J; Kojima M; Miura I; Mori N; Yoshino T; Nakamura S
Blood; 2007 Jan; 109(2):478-85. PubMed ID: 16985183
[TBL] [Abstract][Full Text] [Related]
15. Prostate primary intravascular large B-cell lymphoma: A case report.
Gu L; Li M; Tong G; Wei W; Fan Y; Zhao Y
Urol Case Rep; 2022 Nov; 45():102276. PubMed ID: 36386016
[TBL] [Abstract][Full Text] [Related]
16. Intravascular large B-cell lymphoma: report of three cases and analysis of the mTOR pathway.
Shen Q; Duan X; Feng W; Nguyen N; Lapus A; Brown RE; Chen L
Int J Clin Exp Pathol; 2011; 4(8):782-90. PubMed ID: 22135726
[TBL] [Abstract][Full Text] [Related]
17. A study of PD-L1 expression in intravascular large B cell lymphoma: correlation with clinical and pathological features.
Gupta GK; Jaffe ES; Pittaluga S
Histopathology; 2019 Aug; 75(2):282-286. PubMed ID: 30938862
[TBL] [Abstract][Full Text] [Related]
18. Comparison of serum sIL-2R and LDH levels in patients with intravascular large B-cell lymphoma and patients with advanced stage diffuse large B-cell lymphoma.
Hirami Y; Nishimura MF; Urata T; Morimoto M; Maekawa Y; Yoshino T; Nishimura Y; Sato Y
J Clin Exp Hematop; 2023 Mar; 63(1):25-31. PubMed ID: 36843068
[TBL] [Abstract][Full Text] [Related]
19. [Clinical features of intravascular large B-cell lymphoma: a single-institute retrospective analysis].
Okuno T; Iwata S; Hayakawa H; Miyao K; Kajiguchi T
Rinsho Ketsueki; 2019; 60(3):184-190. PubMed ID: 31068513
[TBL] [Abstract][Full Text] [Related]
20. Clinical and prognostic significance of aberrant T-cell marker expression in 225 cases of de novo diffuse large B-cell lymphoma and 276 cases of other B-cell lymphomas.
Tsuyama N; Ennishi D; Yokoyama M; Baba S; Asaka R; Mishima Y; Terui Y; Hatake K; Takeuchi K
Oncotarget; 2017 May; 8(20):33487-33500. PubMed ID: 28380441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
